Skip to main content
. 2019 May 6;14(5):e0216392. doi: 10.1371/journal.pone.0216392

Fig 1. Effect of various doses of PACAP6-38 on plasma melatonin contents and myofiber area.

Fig 1

(A) A dose-dependent decreased (0, 10, 20, 40 and 60 ng) in plasma melatonin contents with PACAP6-38 treatment. (B) A dose-dependent decreased (0, 10, 20, 40 and 60 ng) in the fiber area with PACAP6-38 treatment. Data are mean ± SEM. * p < 0.05 Vs. 0 μg PACAP6-38 injected dose.